Companies Dominating the Rapid Antigen Testing Landscape
- iHealth Labs, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- NeoDx Biotech Labs
- Abbott Laboratories
- Affinity Biologics, Inc.
- Siemens Healthineers AG
- Epitope Diagnostics, Inc.
- Sino Biological, Inc.
- R-Biopharma AG
- Cell Biolabs, Inc.
- Thermo Fisher Scientific
Browse Key Market Insights with Data Illustration:
In the News
- iHealth Labs, Inc., a digital health startup and the United States' leading provider of at-home COVID tests, launched its Home Collection Kit for syphilis and HIV testing. Anyone over the age of 18 can use the FDA-approved method to take a blood sample in the privacy of their own home to test for syphilis and HIV (I, II, P24 antigen). They can mail the sample to the lab with a pre-paid overnight label and obtain accurate, private results in as little as two days.
- NeoDx Biotech Labs, a Bengaluru-based business, has introduced an in vitro diagnostic (IVD) kit for Ankylosing Spondylitis that uses real-time PCR technology. This kit enables healthcare services to enhance their testing capabilities. The HLA-B27 RT-PCR detection kit for Exon 2/Exon 3 is a real-time PCR test kit that is used to identify Human Leukocyte Antigen B27 in whole blood. HLA-B27 has a strong correlation with the inflammatory conditions of Ankylosing Spondylitis (AS), Psoriasis, Inflammatory Bowel Disease, and Reactive Arthritis. HLA-B27 testing can help in the early diagnosis and treatment of various conditions.
